How I treat heparin-induced thrombocytopenia and thrombosis

被引：62

作者：

Alving, BM ^{[1
]}

机构：

[1] NHLBI, NIH, Bethesda, MD 20892 USA

来源：

BLOOD | 2003年 / 101卷 / 01期

关键词：

D O I：

10.1182/blood-2002-04-1089

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：31 / 37

页数：7

共 44 条

[1]

Bauer TL, 1997, CIRCULATION, V95, P1242

[2] TREATMENT WITH BIVALIRUDIN (HIRULOG) AS COMPARED WITH HEPARIN DURING CORONARY ANGIOPLASTY FOR UNSTABLE OR POSTINFARCTION ANGINA [J].

BITTL, JA ;

STRONY, J ;

BRINKER, JA ;

AHMED, WH ;

MECKEL, CR ;

CHAITMAN, BR ;

MARAGANORE, J ;

DEUTSCH, E ;

ADELMAN, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (12) :764-769

[3]

CHONG BH, 1992, HAEMOSTASIS, V22, P85

[4]

DANHOF M, 1992, HAEMOSTASIS, V22, P73

[5]

DEVALK HW, 1995, ANN INTERN MED, V123, P1

[6]

Eichler P, 2000, BLOOD, V96, P2373

[7] A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia [J].

Farner, B ;

Eichler, P ;

Kroll, H ;

Greinacher, A .

THROMBOSIS AND HAEMOSTASIS, 2001, 85 (06) :950-957

[8] Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis [J].

Fischer, KG ;

van de Loo, A ;

Böhler, J .

KIDNEY INTERNATIONAL, 1999, 56 :S46-S50

[9] Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range [J].

Greinacher, A ;

Eichler, P ;

Lubenow, N ;

Kwasny, H ;

Luz, M .

BLOOD, 2000, 96 (03) :846-851

[10] A STRATEGY FOR A RATIONAL APPROACH TO DESIGNING SYNTHETIC SELECTIVE INHIBITORS [J].

HIJIKATAOKUNOMIYA, A ;

OKAMOTO, S .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1992, 18 (01) :135-149

← 1 2 3 4 5 →